Welcome to our dedicated page for SILICON LABORATORIES SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Silicon Laboratories Inc. filings document an operating semiconductor company focused on low-power wireless connectivity, embedded SoCs and security technology for edge devices. Its 8-K reports cover operating results, financial condition, non-GAAP measures, material-event disclosures, capital-structure items, material agreements and solicitation materials tied to shareholder matters.
Proxy and annual meeting filings disclose board elections, auditor ratification, executive compensation votes and amendments to the 2009 Stock Incentive Plan. The filings also identify the company’s Nasdaq-listed common stock and provide formal records of governance actions, equity-plan matters and stockholder voting outcomes.
SILICON LABORATORIES INC. (SLAB) reported an open-market sale of common stock by senior vice president and general manager Robert J. Conrad. On 2026-08-14, he sold 6,581 shares of common stock at a per-share price of $218.21, leaving him with 23,815 shares held directly after the transaction. The company notes that these shares were sold pursuant to Conrad's Rule 10b5-1 Trading Plan, indicating the trades were executed under a pre-arranged plan.
Silicon Laboratories Inc. reported higher sales but continued losses for the quarter ended July 4, 2026 while progressing toward an all-cash acquisition by Texas Instruments. Under the approved merger agreement, each outstanding share will be converted into $231.00 in cash at closing, expected in the first half of 2027, subject to regulatory and other customary conditions.
Quarterly revenues were $228.2 million, up from $192.8 million a year earlier, driven by both Industrial & Commercial and Home & Life products. Gross margin improved to 61.6%, but higher research and development and selling, general and administrative expenses, including merger-related costs, resulted in a quarterly net loss of $10.6 million. For the first half of 2026, the company lost $26.5 million.
Silicon Labs ended the quarter with $397.2 million in cash, cash equivalents and short-term investments and an undrawn $400 million revolving credit facility. Operating cash flow for the first half swung to an outflow of $9.6 million, mainly due to higher inventories and accounts receivable. Inventory days rose to 127, and the company noted ongoing macroeconomic and geopolitical uncertainties alongside significant expected additional merger-related costs.
Silicon Laboratories Inc. reported strong second-quarter 2026 growth with revenue of $228.2 million, up 18% year-over-year, driven by Industrial & Commercial at $135 million (up 23%) and Home & Life at $93 million (up 12%). Medical applications achieved record revenue, up 78% year-over-year, while bookings and design wins accelerated and channel inventories declined.
GAAP results improved but remained in loss territory, with a GAAP net loss of $10.6 million and GAAP diluted loss per share of $(0.32), versus a larger loss a year ago. Gross margin was 61.6% and GAAP operating loss was $10.7 million. On a non-GAAP basis, excluding stock compensation, intangible amortization, merger-related costs and other items, Silicon Labs generated non-GAAP operating income of $26.8 million and non-GAAP diluted EPS of $0.71, up 545% year-over-year.
For the first six months of 2026, revenue reached $441.7 million with net loss narrowing to $26.5 million. Cash and cash equivalents were $362.2 million and total assets $1.25 billion, though operating cash flow was a modest use of $9.6 million and inventories increased to $123.3 million. In light of the pending acquisition by Texas Instruments, Silicon Labs has suspended forward-looking guidance.
Silicon Laboratories Inc. reported that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act for its planned merger with Texas Instruments Incorporated expired at 11:59 p.m. Eastern Time on May 22, 2026. This expiration satisfies one of the conditions required to close the merger, under which Silicon Labs will become a wholly owned direct subsidiary of Texas Instruments. The closing of the transaction still depends on other customary conditions, including receipt of additional regulatory approvals and satisfaction of requirements in the Merger Agreement.
SILICON LABORATORIES INC. Senior Vice President and CFO Dean Warren Butler reported a routine tax-related share disposition. On the reported date, 6,291 shares of common stock were withheld to cover taxes due upon vesting of a previously reported equity award, rather than sold in the open market. After this withholding, Butler directly holds 43,767 shares of Silicon Labs common stock.
Silicon Laboratories Inc. executive reports routine tax withholding. Sr VP and General Manager Robert J. Conrad had 3,653 shares of common stock withheld on 2026-05-15 to cover taxes upon vesting of a previously reported equity award at an indicated price of $216.59 per share. After this non-market tax-withholding disposition, he directly holds 30,396 shares of Silicon Laboratories common stock.
SILICON LABORATORIES INC. President & CEO Robert Matthew Johnson reported an open-market sale of 8,024 shares of common stock at $216.83 per share on May 18, 2026, leaving him with 80,519 directly held shares.
On May 15, 2026, 10,363 shares were disposed of at $216.59 per share to cover taxes upon the vesting of a previously reported equity award, a tax-withholding event rather than a market sale.
SILICON LABORATORIES INC. Chief Accounting Officer Mark D. Mauldin reported a routine tax-related share disposition. On May 15, 2026, 858 shares of common stock were withheld at $216.59 per share to cover taxes upon vesting of a previously reported equity award. After this withholding, Mauldin directly holds 21,090 shares of common stock. This was a tax-withholding event, not an open-market sale or purchase.
Silicon Laboratories Inc. senior vice president of worldwide sales and marketing Brandon Tolany reported a routine tax-related share disposition. On May 15, 2026, 4,160 shares of common stock were withheld at $216.59 per share to cover taxes upon vesting of a previously reported equity award. Following this withholding, Tolany directly holds 66,935 shares of Silicon Labs common stock. This event reflects compensation-related tax withholding, not an open-market sale.